Avalide 300 mg / 12.5 mg – DIN 02241819
Avalide is Irbesartan and Hydrochlorothiazide 300 mg / 12.5 mg (tablet), sold in Canada. It is used for high blood pressure. It is supplied by Sanofi-Aventis Canada Inc. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Irbesartan and Hydrochlorothiazide 300 mg / 12.5 mg
- Brand
- Avalide
- Strength
- Irbesartan 300 mg / Hydrochlorothiazide 12.5 mg
- Used for
- High blood pressure
- Form
- Tablet
- Manufacturer
- Sanofi-Aventis Canada Inc
- Drug class
- ARB (blood pressure medicine)
- Sold in
- Canada
- DIN
- 02241819
Source: Health Canada's Drug Product Database. Last checked .
Report a mistake
What is Irbesartan and Hydrochlorothiazide used for?
Irbesartan and Hydrochlorothiazide is used for high blood pressure.
- Medicine type
- ARB (blood pressure medicine); thiazide diuretic (water pill)
Official uses from the US prescribing label
Irbesartan and hydrochlorothiazide tablets are indicated for the treatment of hypertension.
Irbesartan and hydrochlorothiazide tablets may be used in patients whose blood pressure is not adequately controlled on monotherapy.
Irbesartan and hydrochlorothiazide tablets may also be used as initial therapy in patients who are likely to need multiple drugs to achieve their blood pressure goals.
The choice of irbesartan and hydrochlorothiazide tablets as initial therapy for hypertension should be based on an assessment of potential benefits and risks.
Patients with stage 2 (moderate or severe) hypertension are at relatively high risk for cardiovascular events (such as strokes, heart attacks, and heart failure), kidney failure, and vision problems, so prompt treatment is clinically relevant. The decision to use a combination as initial therapy should be individualized and may be shaped by considerations such as the baseline blood pressure, the target goal, and the incremental likelihood of achieving goal with a combination compared with monotherapy.
Data from Studies V and VI provide estimates of the probability of reaching a blood pressure goal with irbesartan and hydrochlorothiazide tablets compared to irbesartan or hydrochlorothiazide (HCTZ) monotherapy. The relationship between baseline blood pressure and achievement of a SeSBP <140 or <130 mmHg or SeDBP <90 or <80 mmHg in patients treated with irbesartan and hydrochlorothiazide tablets compared to patients treated with irbesartan or HCTZ monotherapy are shown in Figures 1a through 2b.
*For all probability curves, patients without blood pressure measurements at Week 7 (Study VI) and Week 8 (Study V) were counted as not reaching goal (intent-to-treat analysis).
The above graphs provide a rough approximation of the likelihood of reaching a targeted blood pressure goal (e.g., Week 8 sitting systolic blood pressure ≤140 mmHg) for the treatment groups. The curve of each treatment group in each study was estimated by logistic regression modeling from all available data of that treatment group. The estimated likelihood at the right tail of each curve is less reliable due to small numbers of subjects with high baseline blood pressures.
For example, a patient with a blood pressure of 180/105 mmHg has about a 25% likelihood of achieving a goal of <140 mmHg (systolic) and 50% likelihood of achieving <90 mmHg (diastolic) on irbesartan alone (and lower still likelihoods on HCTZ alone).
The likelihood of achieving these goals on irbesartan and hydrochlorothiazide tablets rises to about 40% (systolic) or 70% (diastolic).
From the FDA-approved label on DailyMed (published Jul 08, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your medicine? Check the box
- The box or bottle shows DIN 02241819.
- It names Avalide, Irbesartan and Hydrochlorothiazide 300 mg / 12.5 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as Avalide by Sanofi-Aventis Canada Inc.
In Canada: prescription only.
Ingredients
Active: Irbesartan, Hydrochlorothiazide
Other Irbesartan and Hydrochlorothiazide pills
- 150H Hydrochlorothiazide and Irbesartan 12.5 mg / 150 mg Orange, oval Used for high blood pressure
- 150H Hydrochlorothiazide and Irbesartan 12.5 mg / 150 mg Orange, oval Used for high blood pressure
- 150H Hydrochlorothiazide and Irbesartan 12.5 mg / 150 mg Orange, oval Used for high blood pressure
- 300H Hydrochlorothiazide and Irbesartan 12.5 mg / 300 mg Orange, oval Used for high blood pressure
- 300H Hydrochlorothiazide and Irbesartan 12.5 mg / 300 mg Orange, oval Used for high blood pressure
- rph I31 Hydrochlorothiazide and Irbesartan 25 mg / 300 mg Brown, oval Used for high blood pressure
- 300 Hydrochlorothiazide and Irbesartan 25 mg / 300 mg Pink, oval Used for high blood pressure
- 300 Hydrochlorothiazide and Irbesartan 25 mg / 300 mg Pink, oval Used for high blood pressure